Stockreport

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

Clene Inc.  (CLNN) 
PDF Data from long-term extension of Phase 2 VISIONARY-MS clinical trial of CNM-Au8® demonstrated significant evidence of repair and remyelination across multiple paraclinic [Read more]